⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ASBP News
Aspire Biopharma Holdings, Inc. Common Stock
Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product
accessnewswire.com
ASBP
Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement
accessnewswire.com
ASBP
Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
accessnewswire.com
ASBP